Ostene CT, Aoc CT, Osteotene, Ceretene
Wax, Bone. 510(k) K091636, from Ceremed , Inc. (Los Angeles, CA). Product code MTJ, class U.
As of Nov 20, 2026, K091636 is an FDA 510(k) held by Ceremed , Inc., substantially equivalent on Jun 22, 2009 after 18 days, with no recalls tied to it in FDA's recall database.
- Review time: 18 days
- Recalls: 0
- Cited as a predicate by: 3 devices
OSTENE ® CT is indicated for use as a water-soluble implant material and for use in the control of bleeding from bone surfaces.
- Ostene CT Soluble Bone Hemostasis Implant Material, Aoc CT, Aoc, Ostene, Osteotene & CereteneK082491 · Ceremed , Inc. · Sep 24, 2008
- MP 719K111524 · Marine Polymer Technologies, Inc. · Jul 22, 2011
- Ceretene Soluble Implant MaterialK103047 · Ceremed , Inc. · Jan 5, 2011
- Ostene CT, Aoc CT, Osteotene, CereteneK102071 · Ceremed , Inc. · Oct 8, 2010
- Permatage XT Settable Nonabsorbable Hemostatic Bone Putty (OS-PER-1001XT)K262769 · Orthocon, Inc. · Sep 3, 2026
- Permatage Flowable, Settable Hemostatic Bone PasteK261439 · Orthocon, Inc. · Jun 3, 2026
- Montage- XT Settable, Resorbable Hemostatic Bone PuttyK232998 · Orthocon, Inc. · Oct 12, 2023
- MONTAGE Settable, Resorbable Hemostatic Bone PuttyK213418 · Orthocon, Inc. · Aug 30, 2023
- Montage Flowable XRO Settable, Resorbable Hemostatic Bone PasteK231386 · Orthocon, Inc. · Jul 11, 2023
- Meril-BonewaxK200452 · M/s. Meril Endo Surgery Private Limited. · Mar 27, 2023
- MONTAGE-XT Settable, Resorbable Hemostatic Bone PuttyK220315 · Orthocon, Inc. · Mar 11, 2022
- HBP7 Settable Hemostatic Bone PuttyK202363 · Orthocon, Inc. · Jan 19, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jun 4, 2009
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files